S. Sengupta
Papers
1
Total Citations
50
H-Index
1
About
S. Sengupta is a pioneering researcher in whole-organism drug discovery, whose work bridges high-throughput screening and in vivo biology. Their most notable contribution is the development of ARQiv-HTS, a versatile platform that enables automated, high-throughput drug screening in live zebrafish embryos. This breakthrough, detailed in their 2016 paper (50 citations), allows researchers to assess compound efficacy and toxicity in a whole-organism context, dramatically accelerating the early stages of drug development. By integrating robotics, imaging, and data analysis, Sengupta’s platform addresses a critical bottleneck in translational research—moving from in vitro assays to physiologically relevant models. Their work has been cited extensively by labs seeking to adopt zebrafish-based screening, highlighting its impact on both academic and pharmaceutical research. Sengupta’s achievements demonstrate a commitment to innovative, cost-effective methodologies that reduce reliance on mammalian models while maintaining predictive power. For students and researchers exploring in vivo drug discovery, Sengupta’s contributions offer a powerful example of how engineering and biology converge to solve real-world challenges in therapeutics.
Research Focus
Key Achievements
Top Papers
- 1